Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients With Rheumatoid or Psoriatic Arthritis

PharmacoEconomics - Open - Switzerland
doi 10.1007/s41669-019-0152-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC